About Bolder Science

Our mission is to provide healthcare professionals with unbiased clinical research information, easily.

Currently, you can access the following clinical trials being conducted worldwide:

378040 studies
in
220 countries
Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 06/15/2021.
This website is for US healthcare professionals

Log In to Bolder Science

or

Don't have an account? Sign Up

Please enter your email address.

You will receive a link to create a new password via email.

Log In

Create an Account

or
(optional) ?

Welcome, !

Please complete the following 4 questions to ensure you receive the information that best suits your needs.

Clinical Trials of Interest

When I’m looking for information on clinical trials, I usually am interested in...

finding clinical trials in which to enroll my patients

Rarely Often

finding newly launched clinical trials (for all phases)

Rarely Often

updates on status changes for clinical trials

Rarely Often

pipeline molecules

Rarely Often

Drug Interventions

Enter up to 3 drug interventions you are currently interested in:

Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 06/15/2021.

24-Hour Ambulatory Blood Pressure Monitoring in Community Pharmacies

Clinicaltrials.gov identifier NCT03920956

Recruitment Status Completed

First Posted April 19, 2019

Last update posted February 5, 2020

Study Description

Brief summary:

This study is designed to explore the feasibility of providing 24-hour ambulatory blood pressure monitoring in community pharmacies. The investigators hypothesize it will be feasible for community pharmacies to provide the service to assist medical providers in the diagnosing and management of high blood pressure. The investigators will also survey participants regarding their experience with the service as well as conduct interviews with participating pharmacists and medical providers to understand their views and opinions on the feasibility of the service.

  • Condition or Disease:Hypertension
  • Intervention/Treatment: Other: ABPM service by Pharmacists
  • Phase: N/A
Detailed Description

N/A

Study Design
  • Study Type: Interventional
  • Actual Enrollment: 53 participants
  • Intervention Model: Single Group Assignment
  • Masking: None (Open Label) ()
  • Primary Purpose: Health Services Research
  • Official Title: Implementation & Evaluation of a 24-Hour Ambulatory Blood Pressure Monitoring Service in Community Pharmacies
  • Actual Study Start Date: July 2019
  • Actual Primary Completion Date: January 2020
  • Actual Study Completion Date: January 2020
Arms and interventions
Arm Intervention/treatment
Experimental: Experimental: 24-hour ABPM by Pharmacists
Patients will meet with the pharmacist to be equipped with a 24-hour ambulatory blood pressure monitor (ABPM). Patients will return the monitor for the pharmacists to download the results to send to their medical provider.
Other: ABPM service by Pharmacists
Patients will receive ABPM services provided by a pharmacist and complete a patient satisfaction survey
Outcome Measures
  • Primary Outcome Measures: 1. Patient satisfaction with the pharmacy service and experience wearing the ABPM [ Time Frame: up to 72 hours ]
    Patient satisfaction will be assessed using a 9 item survey. Participants will rate items on a 5-point scale from strongly agree to strongly disagree.
Eligibility Criteria
  • Ages Eligible for Study: 18 Years and older (Adult, Older Adult)
  • Sexes Eligible for Study: All
  • Accepts Healthy Volunteers: No
Criteria

Inclusion Criteria:

- Adults greater than or equal to 18 years of age suspected by their physician of having
"white coat" or "masked" hypertension (HTN), hypotension symptoms due to
antihypertensive therapy, uncontrolled sustained HTN, requiring additional
confirmation of an initial diagnosis if HTN, or resistant HTN.

Exclusion Criteria:

- Documented past medical history of persistent atrial fibrillation, on hemodialysis,
pregnancy, or dementia.

Contacts and Locations
Contacts
Locations

United States, Virginia
Virginia Commonwealth University
Richmond

Sponsors and Collaborators

Virginia Commonwealth University

Investigators

Principal Investigator: Dave Dixon, PharmD Virginia Commonwealth University

More Information
  • Responsible Party: Virginia Commonwealth University
  • ClinicalTrials.gov Identifier: NCT03920956 History of Changes
  • Other Study ID Numbers: HM20015789
  • First Posted: April 19, 2019 Key Record Dates
  • Last Update Posted: February 5, 2020
  • Last Verified: February 2020
  • Individual Participant
    Data (IPD) Sharing
    Statement:
  • Plan to Share IPD: No
  • Studies a U.S. FDA-regulated Drug Product: No
  • Studies a U.S. FDA-regulated Device Product: No
  • Additional relevant MeSH terms: Hypertension